4 months ago
CAPR
AnalystsBoobalan PachaiyappanBoobalan Pachaiyappan's Stock Forecasts
AnalystsBoobalan Pachaiyappan
Sectors:
Industries:
Analyst Ranking
Top 9%
#449 out of 5217 analysts
Average Return
+54.17%
Win Rate
63%17 out of 27
Risk vs Reward
Poor
Good
Boobalan Pachaiyappan's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Capricor Therapeutics IncCAPR | +419.59% | $5.87 | $30.50 | 2025-11-12 - 2026-03-13 | Strong Buy |
Capricor Therapeutics IncCAPR | +313.00% | $7.39 | $30.50 | 2025-07-14 - 2026-03-13 | Strong Buy |
Cingulate IncCING | +154.09% | $3.42 | $8.69 | 2025-11-19 - 2026-03-13 | Strong Buy |
Capricor Therapeutics IncCAPR | +150.21% | $12.19 | $30.50 | 2025-06-17 - 2026-03-13 | Strong Buy |
Verona Pharma PLCVRNA | +136.53% | $45.20 | $106.91 | 2025-01-10 - 2025-10-07 | Strong Buy |
Boobalan Pachaiyappan Analyst Color
Get additional color on Boobalan Pachaiyappan's coverage of popular stocks
a year ago
CRVO
a year ago
CRVO
Boobalan Pachaiyappan's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Neurosense Therapeutics LtdNRSN | 1 | Strong Buy | $3.00 | +249.24% | Initiates Coverage On | 6 days ago |
Ovid Therapeutics IncOVID | 1 | Strong Buy | $3.00 | +52.28% | Initiates Coverage On | 3 months ago |
Cingulate IncCING | 4 | Strong Buy | $16.00 | +84.12% | Maintains | 4 months ago |
Polypid LtdPYPD | 3 | Strong Buy | $9.00 | +114.80% | Maintains | 4 months ago |
Capricor Therapeutics IncCAPR | 3 | Strong Buy | $13.00 | -57.38% | Maintains | 4 months ago |
Avidity Biosciences IncRNAM | 1 | Strong Buy | $62.00 | +320.34% | Initiates Coverage On | 6 months ago |
Reviva Pharmaceuticals Holdings IncRVPH | 2 | Strong Buy | $60.00 | +2,329.15% | Reiterates | 7 months ago |
Longeveron IncLGVN | 2 | Strong Buy | $3.00 | +208.01% | Maintains | 7 months ago |
Gain Therapeutics IncGANX | 3 | Strong Buy | $6.00 | +146.91% | Maintains | 7 months ago |
Cervomed IncCRVO | 4 | Strong Buy | $16.00 | +276.47% | Reiterates | 7 months ago |
Verona Pharma PLCVRNA | 2 | Strong Buy | $116.00 | +8.50% | Reiterates | 9 months ago |
Entrada Therapeutics IncTRDA | 1 | Strong Buy | $29.00 | N/A | Initiates Coverage On | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.